Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Cazzato, G. Ambrogio, F. Pisani, M. C. Colagrande, A. Arezzo, F. Cascardi, E. Dellino, M. Macorano, E. Trilli, I. Parente, P. Lettini, T. Romita, P. Marzullo, A. Ingravallo, G. Foti, C.

Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Limbu, Y. B. Gautam, R. K.

How Well the Constructs of Health Belief Model Predict Vaccination Intention: A Systematic Review on COVID-19 Primary Series and Booster Vaccines

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Yuan, D. Liu, S. Liu, Y. Ouyang, F. Ai, W. Shi, L. Liu, X. Qiu, T. Wang, B. Zhou, Y.

HPV Infection Profiles among People Living with HIV and HPV Vaccine Acceptance among Individuals with Different HIV Infection Statuses in China: A Systematic Meta-Analysis

  • Western Pacific
  • China
  • All age groups
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Amantea, C. Foschi, N. Gavi, F. Borrelli, I. Rossi, M. F. Spuntarelli, V. Russo, P. Gualano, M. R. Santoro, P. E. Moscato, U.

HPV Vaccination Adherence in Working-Age Men: A Systematic Review and Meta-Analysis

  • Adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Zewdie, A. Kasahun, A. W. Habtie, A. Gashaw, A. Ayele, M.

Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Adolescents
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Ellingson, M. K. Sheikha, H. Nyhan, K. Oliveira, C. R. Niccolai, L. M.

Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Alotaibi, A. S. Shalabi, H. A. Alhifany, A. A. Alotaibi, N. E. Alnuhait, M. A. Altheaby, A. R. Alhazmi, A. Y.

Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Farhadian, N. Sharifi, S. Taghadosi, M. Farhadian, M. Vaziri, S.

Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Martinelli, S. Pascucci, D. Laurenti, P.

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Notarte, K. I. Catahay, J. A. Peligro, P. J. Velasco, J. V. Ver, A. T. Guerrero, J. J. Liu, J. Lippi, G. Benoit, S. W. Henry, B. M. Fernández-de-Las-Peñas, C.

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...